AMNIOX® Medical is a leader in restorative tissue therapies. We have over 25 years of National Institute of Health (NIH) sponsored research, 130,000 human implants, and 300 peer-reviewed scientific publications.

Michael Harrison, MD, often cited as the “Father of Fetal Surgery”, discusses the scarless regenerative healing properties of fetal tissues. Transplantation of these tissues as been shown to modulate adult environments to prevent pathological, chronic inflammation.

Scheffer Tseng, MD, PhD discusses his long research history on the unique biological properties of Amniotic Membrane and Umbilical Cord, electively-donated fetal tissues with regenerative healing properties.

Scheffer Tseng, MD, PhD discusses the superior technology of cryopreservation as a means to preserve and retain the biologic properties innate to fetal tissues.

Scheffer Tseng, MD, PhD discusses the early clinical need for Amniotic Membrane transplantation in ophthalmology and its demonstrated success as a stem cell matrix.

Thomas Lee, MD discusses the ability of Cryopreserved Amniotic Membrane and Umbilical Cord to control inflammation and scar formation, two previously unmet clinical needs.

Gregory Berlet, MD discusses the benefits of Amniotic Membrane and Umbilical Cord transplantation for inflammatory modulation and scar reduction following Foot and Ankle or Sports Medicine surgery.

Gregory Berlet, MD discusses the patient’s perspectives and experiences following Amniotic Membrane and Umbilical Cord transplantation during reconstructive tendon surgery.

Surgeons offer clinical feedback on the use and outcomes of Cryopreserved Amniotic Membrane and Umbilical Cord transplantation.

Christopher Hyer, DPM discusses the addition of Cryopreserved Amniotic Membrane and Umbilical Cord transplantation to his post-operative protocols to reduce scar formation and promote healing and recovery.